Rubio, Karla http://orcid.org/0000-0002-8337-3106
Müller, Jason M.
Mehta, Aditi
Watermann, Iris
Olchers, Till
Koch, Ina
Wessels, Sabine
Schneider, Marc A. http://orcid.org/0000-0001-8269-3821
Araujo-Ramos, Tania
Singh, Indrabahadur
Kugler, Christian
Stoleriu, Mircea Gabriel http://orcid.org/0000-0002-1288-809X
Kriegsmann, Mark
Eichhorn, Martin
Muley, Thomas
Merkel, Olivia M. http://orcid.org/0000-0002-4151-3916
Braun, Thomas http://orcid.org/0000-0002-6165-4804
Ammerpohl, Ole
Reck, Martin
Tresch, Achim http://orcid.org/0000-0002-4146-6371
Barreto, Guillermo http://orcid.org/0000-0002-7777-4712
Funding for this research was provided by:
European Research Council (ERC-2014-StG – 637830)
Deutsches Zentrum für Lungenforschung (Clinical study EMoLung)
Deutsche Forschungsgemeinschaft (SI 2620/1-1, Excellence Cluster Cardio-Pulmonary Institute (CPI), Transregional Collaborative Research Center TRR 81 TP A02, SFB 1213 TP B02, TRR 267 TP A05)
Deutsche Forschungsgemeinschaft (BA 4036/4-1)
“Lorraine Université d'Excellence” (LUE) and the dispositive “Future Leader” (EPIGENIAL)
Article History
Received: 16 July 2023
Accepted: 22 September 2023
First Online: 3 October 2023
Declarations
:
: The study was performed according to the principles set out in the WMA Declaration of Helsinki and to the protocols approved by the institutional review board and ethics committee of the University of Lübeck (AZ: 17-065). A flowchart depicting different steps of the non-interventional clinical study EMoLung is represented in Fig. S1a (Supplementary Material). All participants provided informed written consent.
: Not applicable.
: Sabine Wessels reports grants and personal fees from German Center for Lung Research (DZL) during the conduct of the study. Thomas Muley reports grants and non-financial support, outside the submitted work, from Roche Diagnostics GmbH, Penzberg, Germany. Martin Reck reports personal fees, outside the submitted work, from Amgen, AstraZeneca, BMS, Boehringer-Ingelheim, Lilly, Merck, MSD, Mirati, Novartis, Pfizer, Roche and Samsung Bioepis. Guillermo Barreto reports personal fees as scientific advisor, outside the submitted work, from a company in USA. There are two patents related to this work, European Patent with the number EP2999797A1 and USA Patent with the number US20200181717A1. The remaining authors declare that they have no competing interests with this study.